Diabetes is a metabolic disorder and long standing diabetic patients are prone to get neuropathy. The pain I the neuropathy is unbearable and cannot be treated by cox inhibitors. Pregabalin is a structural similar drug of the inhibitory neurotransmitter γ-amino butyric acid but it is not functionally the same. It binds to the α-2-δ subunit of voltage-gated calcium channels reducing the release of several excitatory neurotransmitters and blocking the development of hyprealgesia and central sensitization. This study puts in a effort to find the efficacy of this drug in controlling the diabetic neuropathy pain